Sponsor: 
GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use from birth.

Recombinant hepatitis B vaccine

Adult formulation

Each 1.0 mL monodose vial or pre-filled syringe contains:

  • 20 µg recombinant hepatitis B surface antigen (HBsAg) protein, adsorbed onto 0.5 mg aluminium as aluminium hydroxide

Paediatric formulation

Each 0.5 mL monodose vial or pre-filled syringe contains:

  • 10 µg HBsAg protein, adsorbed onto 0.25 mg aluminium as aluminium hydroxide

Both formulations may contain yeast proteins.

The product information and consumer medicine information for Engerix-B have more details.

Audience: 
Infants and children
Previous

Dukoral

Next

Fluad

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018

Definitions

HBsAg
hepatitis B surface antigen